Advertisement
Advertisement

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

28.76
USD
Sponsored
-1.26
-4.20%
Jan 29, 14:33 UTC -5
Open

PRCT Earnings Reports

Positive Surprise Ratio

PRCT beat 10 of 17 last estimates.

59%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$96.02M
/
-$0.33
Implied change from Q3 25 (Revenue/ EPS)
+15.23%
/
-13.16%
Implied change from Q4 24 (Revenue/ EPS)
+40.72%
/
-5.71%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On Nov 04, 2025, PRCT reported earnings of -0.38 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 9.48% surprise. Revenue reached 83.33 million, compared to an expected 82.56 million, with a 0.93% difference. The market reacted with a -9.74% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 96.02 million USD, implying an decrease of -13.16% EPS, and increase of 15.23% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
FAQ
For Q3 2025, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.38, beating estimates by 9.48%, and revenue of $83.33M, 0.93% above expectations.
The stock price moved down -9.74%, changed from $35.02 before the earnings release to $31.61 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 16 analysts, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.33 and revenue of $96.02M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement